Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOMPERIDONE for Maternal exposure timing unspecified: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 16 adverse event reports in the FDA FAERS database where DOMPERIDONE was used for Maternal exposure timing unspecified.

Most Reported Side Effects for DOMPERIDONE

Side Effect Reports % Deaths Hosp.
Off label use 1,156 25.6% 823 838
Vomiting 918 20.3% 647 549
Condition aggravated 902 20.0% 599 704
Abdominal pain upper 898 19.9% 657 524
Dyspnoea 859 19.0% 554 565
Dizziness 858 19.0% 703 461
Drug ineffective 850 18.8% 576 680
Asthenia 835 18.5% 675 546
Arthralgia 827 18.3% 746 531
Fatigue 814 18.0% 626 601
Pain 781 17.3% 542 608
Gastrooesophageal reflux disease 769 17.0% 539 560
Headache 754 16.7% 571 535
Wheezing 753 16.7% 529 624
Diarrhoea 751 16.6% 646 481

Other Indications for DOMPERIDONE

Product used for unknown indication (3,218) Nausea (198) Vomiting (92) Foetal exposure during pregnancy (80) Impaired gastric emptying (53) Irritable bowel syndrome (52) Lactation disorder (50) Antiemetic supportive care (43) Supportive care (32) Gastrooesophageal reflux disease (29)

Other Drugs Used for Maternal exposure timing unspecified

VALPROATE (1,477) ADALIMUMAB (1,280) NATALIZUMAB (492) RITONAVIR (486) EMTRICITABINE\TENOFOVIR DISOPROXIL (333) LOPINAVIR\RITONAVIR (278) DIVALPROEX (254) INTERFERON BETA-1A (245) DIMETHYL (212) ATAZANAVIR (169)

Related Pages

DOMPERIDONE Full Profile All Maternal exposure timing unspecified Drugs DOMPERIDONE Demographics DOMPERIDONE Timeline